Naloxone Hydrochloride Spray
Product Images NDC 71205-707

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 71205-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

Figure 1 (a) (2y2 Figure 1 (a))
This is a description of different administration methods and doses of Naloxone, a medication used to rapidly reverse opioid overdose. The text includes the plasma concentration measured in ng/mL, along with dosage information for nasal spray and IM injection routes, given at different concentrations and intervals of time post-dose.*
FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

Figure 1 (b) (2y2 Figure 1 (b))
This text provides instructions for administering Naloxone, a medication used to reverse opioid overdose. It lists different dosages of the medication with corresponding plasma concentration levels in ng/mL, based on the method of administration (either through one or both nostrils or via intramuscular injection), and time interval from the dose (in hours).*
FDA Label Image

Step 3 (2y2 Step 3)

FDA Label Image

Step 4 (2y2 Step 4)

FDA Label Image

Step 5 (2y2 Step 5)

FDA Label Image

Step 7 (2y2 Step 7)

FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Step 2 (Image 01)

FDA Label Image

Step1-image1 (Image 02)

FDA Label Image

71205-707-02 (Image 04)

71205-707-02 (Image 04)
This is a description of a Naloxone HCI 4mg nasal spray, with NDC 71205-707-02, available on prescription only. It is a relabeled product by Proficient Re LP based in Thousand Oaks, California. The product is designed for use in the nose only and each 0.1ml of the nasal spray contains 4mg of naloxone hydrochloride equivalent to 3.6mg of naloxone in purified water. A package insert is provided with important usage instructions. The product should be stored below 77°F (25°C) and kept away from children. The expiry date is not available.*
FDA Label Image

Step 1 (Quick Start Guide Step 1)

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

FDA Label Image

Step 3 (Quick Start Guide Step 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.